These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 16894188)

  • 1. A molecular approach to the identification of cytotoxic T-lymphocyte epitopes within equine herpesvirus 1.
    Kydd JH; Davis-Poynter NJ; Birch J; Hannant D; Minke J; Audonnet JC; Antczak DF; Ellis SA
    J Gen Virol; 2006 Sep; 87(Pt 9):2507-2515. PubMed ID: 16894188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of equine herpesvirus-1 antigens recognized by cytotoxic T lymphocytes.
    Soboll G; Whalley JM; Koen MT; Allen GP; Fraser DG; Macklin MD; Swain WF; Lunn DP
    J Gen Virol; 2003 Oct; 84(Pt 10):2625-2634. PubMed ID: 13679596
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
    Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
    Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
    Kydd JH; Wattrang E; Hannant D
    Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The common equine class I molecule Eqca-1*00101 (ELA-A3.1) is characterized by narrow peptide binding and T cell epitope repertoires.
    Bergmann T; Moore C; Sidney J; Miller D; Tallmadge R; Harman RM; Oseroff C; Wriston A; Shabanowitz J; Hunt DF; Osterrieder N; Peters B; Antczak DF; Sette A
    Immunogenetics; 2015 Nov; 67(11-12):675-89. PubMed ID: 26399241
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination of ponies with the IE gene of EHV-1 in a recombinant modified live vaccinia vector protects against clinical and virological disease.
    Soboll G; Breathnach CC; Kydd JH; Hussey SB; Mealey RM; Lunn DP
    Vet Immunol Immunopathol; 2010 May; 135(1-2):108-117. PubMed ID: 20018383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immediate-early protein of equid herpesvirus type 1 as a target for cytotoxic T-lymphocytes in the Thoroughbred horse.
    Kydd JH; Case R; Minke J; Audonnet JC; Wagner B; Antczak DF
    J Gen Virol; 2014 Aug; 95(Pt 8):1783-1789. PubMed ID: 24836672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1.
    Allen G; Yeargan M; Costa LR; Cross R
    J Virol; 1995 Jan; 69(1):606-12. PubMed ID: 7983765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
    Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of equine herpesvirus type 1 pUL56 and its role in virus-induced downregulation of major histocompatibility complex class I.
    Ma G; Feineis S; Osterrieder N; Van de Walle GR
    J Virol; 2012 Apr; 86(7):3554-63. PubMed ID: 22278226
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gag protein epitopes recognized by ELA-A-restricted cytotoxic T lymphocytes from horses with long-term equine infectious anemia virus infection.
    Zhang W; Lonning SM; McGuire TC
    J Virol; 1998 Dec; 72(12):9612-20. PubMed ID: 9811694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
    Platt R; Sponseller BA; Chiang YW; Roth JA
    Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equine major histocompatibility complex class I molecules act as entry receptors that bind to equine herpesvirus-1 glycoprotein D.
    Sasaki M; Hasebe R; Makino Y; Suzuki T; Fukushi H; Okamoto M; Matsuda K; Taniyama H; Sawa H; Kimura T
    Genes Cells; 2011 Apr; 16(4):343-57. PubMed ID: 21306483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets.
    Breathnach CC; Soboll G; Suresh M; Lunn DP
    Vet Immunol Immunopathol; 2005 Feb; 103(3-4):207-15. PubMed ID: 15621307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single amino acid difference within the alpha-2 domain of two naturally occurring equine MHC class I molecules alters the recognition of Gag and Rev epitopes by equine infectious anemia virus-specific CTL.
    Mealey RH; Lee JH; Leib SR; Littke MH; McGuire TC
    J Immunol; 2006 Nov; 177(10):7377-90. PubMed ID: 17082657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presentation and binding affinity of equine infectious anemia virus CTL envelope and matrix protein epitopes by an expressed equine classical MHC class I molecule.
    McGuire TC; Leib SR; Mealey RH; Fraser DG; Prieur DJ
    J Immunol; 2003 Aug; 171(4):1984-93. PubMed ID: 12902502
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.
    Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
    Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
    Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of equine herpesvirus-specific effector and memory cytotoxic immunity in the equine upper respiratory tract.
    Breathnach CC; Yeargan MR; Timoney JF; Allen GP
    Vet Immunol Immunopathol; 2006 May; 111(1-2):117-25. PubMed ID: 16472871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of equid herpesvirus 1-specific, CD8+, cytotoxic T lymphocyte precursor frequencies in ponies.
    O'Neill T; Kydd JH; Allen GP; Wattrang E; Mumford JA; Hannant D
    Vet Immunol Immunopathol; 1999 Sep; 70(1-2):43-54. PubMed ID: 10507286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.